EP1079793A1 - Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien - Google Patents

Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien

Info

Publication number
EP1079793A1
EP1079793A1 EP00912566A EP00912566A EP1079793A1 EP 1079793 A1 EP1079793 A1 EP 1079793A1 EP 00912566 A EP00912566 A EP 00912566A EP 00912566 A EP00912566 A EP 00912566A EP 1079793 A1 EP1079793 A1 EP 1079793A1
Authority
EP
European Patent Office
Prior art keywords
use according
keratin
composition
acid
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00912566A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christian Springob
Manuela Javet
Ursula Hehner
Thomas Kripp
Beate Grasser
Kirstin Uhl
Günther LANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Deutschland GmbH
Original Assignee
Wella GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wella GmbH filed Critical Wella GmbH
Publication of EP1079793A1 publication Critical patent/EP1079793A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Definitions

  • the present invention relates to the use of reducing aliphatic or cyclic compounds as a means for hardening, strengthening and improving the structure (restructuring) of materials containing keratin, in particular damaged keratin fibers, and for increasing the volume of fibers containing keratin, in particular human hair.
  • the present invention further relates to a method for hardening, strengthening and improving the structure (restructuring) of materials containing keratin, and to a method for increasing the volume of fibers containing keratin.
  • keratin fibers for example human
  • a common method for measuring the degree of damage to hair is the tensile strength measurement.
  • the force that is required to break individual hairs is measured with a tension-strain measuring device.
  • the so-called bundle tensile strength (BZF) is determined from these individual tensile strength measurement values, which differ from one another due to the different hair diameters, by first calculating the tensile strength for a hair diameter of 0.08 mm (average diameter) from the individual values, taking into account the respective hair diameter. By including the hair density, it is finally converted into the unit of bundle tensile strength (cN / tex). The greater the numerical value of the tensile strength or the bundle tensile strength, the less the hair damage.
  • the object underlying the present invention was to provide a preparation, in particular a cosmetic preparation, which eliminates the aforementioned disadvantages.
  • this object is achieved by using a preparation comprising at least one reducing aliphatic or cyclic compound containing the atom grouping
  • EP-PS 0 401 454 proposes to remove residues of hydrogen peroxide which remain in human hair after an oxidative treatment with an aqueous solution of ascorbic acid. Effervescent tablets containing ascorbic acid are suitable for this, which are dissolved in water immediately before use, which is then used for hair rinsing.
  • ascorbic acid is used in DE-OS 1 444 216 in a liquid hair dye in order to make the otherwise unstable liquid agent stable.
  • the oxidation hair dye according to DE-OS 3 642 097 also contains ascorbic acid as a stabilizer. It was all the more surprising to find that ascorbic acid can be used to improve the structure (hardening, strengthening, restructuring) of materials containing keratin, in particular fibers containing keratin, for example human hair.
  • the use according to the invention can also have advantageous effects in the case of conditions or changes in the structure of keratin-containing materials which are caused by physiological processes. For example, age-related brittle keratin-containing material (hair or nails) or fine hair, which can be congenital or acquired depending on age (baby hair, aging hair).
  • composition stands.
  • the present invention thus relates to the use of at least one reducing aliphatic or cyclic compound, individually or as a mixture, containing the atom grouping
  • Epimeric and tautomeric forms are included as isomeric forms of these atomic groupings contained in the relevant aliphatic and cyclic compounds.
  • reductones are preferably used.
  • the present invention also includes a method for hardening, strengthening and restructuring keratin-containing materials and / or for increasing the volume of keratin-containing fibers, which is characterized in that a composition comprising at least one reducing aliphatic or cyclic compound containing the atomic grouping
  • Ascorbic acid or isoascorbic acid or its salts or esters for example 6-O-palmitoyl ascorbate, ascorbyl phosphate, hydroxypropanedial (triose reductone), 2,3-dihydroxy-2-cyclopenten-1-one (reductic acid), for example, can advantageously be used for the purposes mentioned ), or mixtures of these compounds, can be used.
  • the use of ascorbic acid or isoascorbic acid, especially ascorbic acid is preferred.
  • the free acid can also be obtained in situ from the salts, for example the alkali metal ascorbates or alkaline earth metal ascorbates or the alkali metal isoascorbates or alkaline earth metal isoascorbates, by adding a physiologically tolerated acid (for example citric acid, oxyacetic acid, glyoxylic acid, 2-acid acid, 2-acid acid, 2-acid acid), be generated.
  • a physiologically tolerated acid for example citric acid, oxyacetic acid, glyoxylic acid, 2-acid acid, 2-acid acid, 2-acid acid
  • the calcium salt, the magnesium salt and the sodium salt of ascorbic acid or isoascorbic acid are suitable as ascorbic acid salts or isoascorbic acid salts.
  • any combinations of the reducing aliphatic and / or cyclic compounds mentioned can also be used for the purpose mentioned. It is preferred to use a combination of ascorbic acid or isoascorbic acid or its salts or esters, for example 6-O-palmitoyl-ascorbic acid, ascorbyl phosphate,
  • Hydroxypropanedial triose reductone
  • 2,3-dihydroxy-2-cyclopenten-1-one reductic acid
  • mixtures of these compounds for hardening, strengthening, structural improvement (restructuring) and volume increase of materials which contain structure-damaged keratin, in particular fibers containing keratin, for example Hair.
  • the reducing aliphatic and / or cyclic compound on which the invention is based is covered with a protective layer.
  • cellulose-coated or silicone-coated compounds are suitable.
  • 0.3 to 50 percent by weight, in particular 0.5 to 10 percent by weight, of the reducing aliphatic and / or cyclic compound in question can be used as preferred amounts.
  • composition described for the use according to the invention can be present in all suitable formulations which are known in the cosmetic or pharmaceutical industry.
  • the composition can be present as an aqueous or aqueous-alcoholic solution, as a gel, cream, emulsion or foam, the composition can be made up both in the form of a one-component preparation and in the form of a multi-component preparation.
  • the composition can contain at least one reducing aliphatic and / or cyclic compound according to the present invention (for example ascorbic acid, isoascorbic acid, sodium ascorbate) together with suitable auxiliaries and carriers (for example thickeners, acids, fragrances, solvents, salts, wetting agents, UV absorber).
  • composition is in the form of a multi-component preparation, this can consist of at least two different components that are spatially separated from one another until use.
  • a first component can either contain the reducing aliphatic and / or cyclic compound (active ingredient) on which the present invention is based on its own or the active ingredient can be used together with an auxiliary (for example a thickener), advantageously in solid dry form (for example as a powder in compressed or non-compressed form, as granules or tablets), mixed in this first component.
  • auxiliary for example a thickener
  • a second or further component contains only auxiliaries and carriers.
  • a multi-component preparation can be advantageous with regard to handling and stability (storage stability) of the active substances on which the invention is based.
  • the invention also includes the use of a composition which is characterized in that it is present as a one-component preparation or as a multiple-component preparation, the composition of the single-component preparation containing at least one reducing aliphatic and / or cyclic compound together with auxiliaries and additives, and the composition in the multicomponent preparation comprises a first component which contains at least one reducing aliphatic and / or cyclic compound with or without auxiliaries and additives and that a second component contains only auxiliaries and excipients or wherein the composition in the multicomponent preparation comprises at least three different components, where at least two of them contain at least one different reducing aliphatic and / or cyclic compound and that at least one further component contains only auxiliaries and additives lt.
  • the composition according to the invention can also be made up as tablets - also effervescent tablets - or granules.
  • the composition is then prepared from this before use with cold or warm water, optionally with the addition of one or more of the auxiliaries mentioned below.
  • these auxiliaries if they are in solid form
  • these auxiliaries are already contained in the powder or granules or the effervescent tablet.
  • composition on which the invention is based can include additional auxiliaries, such as, for example, solvents such as water, lower aliphatic alcohols, for example ethanol, n-propanol and isopropanol, glycol ethers or glycols such as glycerol and in particular 1,2-propanediol, and also wetting agents or emulsifiers from the classes of anionic, cationic, amphoteric or non-ionic surface-active substances such as fatty alcohol sulfates, ethoxylated fatty alcohol sulfates, alkyl sulfonates, alkyl benzene sulfonates,
  • Alkyltrimethylammonium salts alkylbetaines, ethoxylated fatty alcohols, ethoxylated nonylphenols, fatty acid alkanolamides, ethoxylated fatty alcohols, ethoxylated nonylphenols, fatty acid alkanolamides, ethoxylated fatty acid ester, also thickeners such as higher fatty alcohols, starch or cellulose derivatives, thiols, ketocarboxylic acids (oxo carboxylic acids), in particular ⁇ -ketocarboxylic acids or their physiologically tolerable Contain salts, UV absorbers, perfumes, dyes, hair pretreatment agents, conditioners, hair swelling agents, preservatives, petroleum jelly, paraffin oil and fatty acids as well as care substances such as cationic resins, lanolin derivatives, cholesterol, pantothenic acid and betaine.
  • thickeners such as higher fatty alcohols, starch or cellulose derivatives, thiols
  • the pH of the composition is preferably about 1.8 to 7.0, in particular 3.0 to 6.5.
  • the desired pH can be obtained by adding further acids, for example ⁇ -hydroxycarboxylic acids such as lactic acid, tartaric acid, citric acid or malic acid, phosphoric acid, acetic acid, glycolic acid, salicylic acid, glutathione or gluconic acid lactone, or else alkalizing agents such as Alkanolamines, alkylamines, alkali hydroxides, ammonium hydroxides, alkali carbonates, ammonium carbonates or alkali phosphates can be adjusted.
  • ⁇ -hydroxycarboxylic acids such as lactic acid, tartaric acid, citric acid or malic acid, phosphoric acid, acetic acid, glycolic acid, salicylic acid, glutathione or gluconic acid lactone
  • alkalizing agents such as Alkanolamines, alkylamines, alkali hydroxides, ammonium hydroxides, alkal
  • the composition can either remain at the application site, that is to say after it has been brought into contact with the material to be treated with keratin, or can be removed again after a contact time of between one minute and approximately one hour at a temperature between 20 ° C. and approximately 60 ° C.
  • the process depends on the nature of the material to be treated and can therefore be varied.
  • the composition can also remain there (for example in the hair) or be rinsed out after use.
  • the exposure time of the composition is 1 to 60 minutes, in particular 5 to 20 minutes, depending on the temperature (about 20 to 50 degrees Celsius), the repair effect (hardening, restructuring, possibly the associated increase in volume) being accelerated by adding heat and after the exposure time, the hair is rinsed with water and, if necessary, washed with a shampoo.
  • the composition according to the invention can also be used as a pretreatment agent before hair coloring or before a permanent wave treatment in order to prevent hair damage from these oxidative treatments.
  • Component A ascorbic acid 5.00 g
  • Methylhydroxyethylcellulose (Tylose MHB 10.000P from Hoechst / FRG) 1.50 g
  • Component B citric acid 5.00 g
  • Trisodium citrate dihydrate 0.80 g
  • Components A and B were combined and shaken well.
  • the resulting gel was allowed to act on a bleached strand of hair at 40 ° C for 15 minutes under a plastic cover.
  • the bundle tensile strength was then compared with an otherwise untreated bleached strand.
  • the bundle tensile strength in cN / tex was as follows:
  • Component A is a compound having Component A:
  • Component B is a compound having Component B:
  • Components A and B were combined and shaken well. The cure was allowed to act on a bleached strand of hair at 40 degrees C for 15 minutes under a plastic cover. The bundle tensile strength was then compared with an otherwise untreated bleached strand. The bundle tensile strength in cN / tex was as follows:
  • Methylhydroxyethylcellulose (Tylose MHB 10.000P from Hoechst / FRG) 1.50 g
  • Trisodium citrate dihydrate 0.30 g
  • Methylhydroxyethylcellulose (Tylose MHB 10.000P from Hoechst / FRG) 1.50 g water ad 100.00 g
  • the pH was adjusted to pH 3.0 to 6.0 with trisodium citrate dihydrate.
  • Methylhydroxyethylcellulose (Tylose MHB 10.000P from Hoechst / FRG) 1.50 g
  • Component A is a compound having Component A:
  • Component B is a compound having Component B:
  • Components A and B were combined and shaken well. The resulting solution was sprayed onto the hair, combed and left there.
  • Methylhydroxyethylcellulose (Tylose MHB 10.000P from Hoechst / FRG) 1.50 g
  • the pH was adjusted to 3.0 to 6.0 with trisodium citrate dihydrate.
  • Citric acid 7.40 g trisodium citrate dihydrate 1.00 g
  • Citric acid 7.40 g
  • Trisodium citrate dihydrate 0.60 g
  • Citric acid 7.40 g
  • Trisodium citrate dihydrate 1.00 g hydroxyethyl cellulose 1.50 g
  • Component A is a compound having Component A:
  • Component B is a compound having Component B:
  • Components A and B were combined and shaken well. The cure was allowed to act on the hair at 40 degrees C for 15 minutes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP00912566A 1999-03-25 2000-03-08 Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien Withdrawn EP1079793A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19913427 1999-03-25
DE19913427A DE19913427A1 (de) 1999-03-25 1999-03-25 Verwendung von reduzierenden Verbindungen zur Verstärkung und Strukturverbesserung von Keratin enthaltenden Materialien
PCT/EP2000/002003 WO2000057839A1 (de) 1999-03-25 2000-03-08 Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien

Publications (1)

Publication Number Publication Date
EP1079793A1 true EP1079793A1 (de) 2001-03-07

Family

ID=7902290

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00912566A Withdrawn EP1079793A1 (de) 1999-03-25 2000-03-08 Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien

Country Status (6)

Country Link
US (1) US6482808B1 (pt)
EP (1) EP1079793A1 (pt)
JP (1) JP2002540128A (pt)
BR (1) BR0005546A (pt)
DE (1) DE19913427A1 (pt)
WO (1) WO2000057839A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815900B1 (en) * 2000-07-11 2010-10-19 L'ORéAL S.A. Use of C3-C5 monosaccharides to protect keratinous fibers
DE10061420A1 (de) * 2000-12-09 2002-06-13 Henkel Kgaa Neue Verwendung von Polyhydroxyverbindungen
JP4582943B2 (ja) * 2001-03-23 2010-11-17 花王株式会社 毛髪損傷度の評価方法
DE10114561A1 (de) 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
US20070028938A1 (en) * 2003-09-15 2007-02-08 Laxmikant Tiwari Method of straightening hair with compositions comprising an alpha-hydroxy acid and a reducing agent
US7820147B2 (en) * 2005-11-18 2010-10-26 Mata Michael T Hair restorative compositions and methods for treating damaged hair and safely chemically treating hair
JP5275570B2 (ja) * 2007-01-30 2013-08-28 花王株式会社 毛髪うねり改善剤
DE102010051725A1 (de) * 2010-11-19 2012-05-24 Merck Patent Gmbh Verwendung von Ascorbinsäurederivaten zur Färbung von keratinhaltigen Fasern
EP2570190A1 (en) 2011-09-15 2013-03-20 Braun GmbH Spray nozzle for dispensing a fluid and sprayer comprising such a spray nozzle
US9358197B2 (en) 2012-06-15 2016-06-07 The Procter & Gamble Company Method employing polyols when chemically modifying the internal region of a hair shaft
MX2015005779A (es) 2013-06-28 2015-09-23 Procter & Gamble Producto de laca en aerosol para el cabello que comprende un dispositivo de rociado.
JP6707449B2 (ja) * 2013-11-21 2020-06-10 ユニリーバー・ナームローゼ・ベンノートシヤープ 毛髪の処理方法
US10588839B2 (en) 2013-11-21 2020-03-17 Conopco, Inc. Method of shaping hair
EP2990796A1 (en) 2014-08-29 2016-03-02 The Procter and Gamble Company Device for testing the properties of hair fibres
EP3302408B1 (en) 2015-06-01 2019-08-14 The Procter and Gamble Company Aerosol hairspray product comprising a spraying device
US10300003B2 (en) * 2015-07-21 2019-05-28 Conopco, Inc. Hair shaping composition
JP6892999B2 (ja) * 2016-06-29 2021-06-23 日光ケミカルズ株式会社 損傷毛髪改善剤及びそれを含有する損傷毛髪改善化粧料
KR102354282B1 (ko) * 2017-05-17 2022-01-21 주식회사 엘지생활건강 에리소르빈산을 포함하는 화장료 조성물
WO2019030872A1 (ja) * 2017-08-09 2019-02-14 花王株式会社 毛髪処理方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603639A (en) 1978-05-26 1981-11-25 Haggar H Composition for application to the hair and scalp
DE2824025B2 (de) * 1978-06-01 1981-04-16 Henkel KGaA, 4000 Düsseldorf Verwendung von Glucose zur Verbesserung der Struktur und der Naßkämmbarkeit von Haaren
US4659566A (en) 1984-08-21 1987-04-21 Petrow Henry G Compositions and methods for permanently waving or straightening hair
US4786493A (en) 1985-11-22 1988-11-22 Estee Lauder Inc. Hair protection composition
CH677188A5 (pt) * 1989-03-16 1991-04-30 Mono Cosmetic S A
IL91928A (en) 1989-10-08 1994-07-31 Amrad Res & Dev Pharmaceutical compositions containing prolactin
JP2926432B2 (ja) * 1990-06-11 1999-07-28 株式会社林原生物化学研究所 養毛剤
US5042988A (en) 1990-10-31 1991-08-27 Clairol Incorporated Compositions containing nitroaniline dyes having a carbamide substituent group
WO1992011042A1 (en) 1990-12-19 1992-07-09 Allergan, Inc. Compositions and methods for contact lens disinfecting
GR1002610B (el) * 1991-01-02 1997-02-20 Johnson & Johnson Consumer Products Inc. Θεραπευτικες συνθεσεις πληγων που περιεχουν παραγοντα αναπτυξης ινοβλαστων και ασκορβικον οξυ.
US5254336A (en) 1992-09-24 1993-10-19 Helene Curtis, Inc. Method of increasing hair shine and repairing alkaline-damaged hair
ATE196599T1 (de) 1993-01-19 2000-10-15 Nicholas V Dr Perricone Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden
DE4336903A1 (de) 1993-10-28 1995-05-04 Edith Bachor Kosmetische Formulierungen zur Behandlung von Bindegewebsschwäche und deren Folgeerscheinungen sowie Verfahren zu deren Behandlung
FR2719468B1 (fr) * 1994-05-05 1996-05-31 Oreal Compositions cosmétiques à base de certains bioflavonoïdes et utilisations notamment dans le domaine capillaire.
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
DE19647493C1 (de) * 1996-11-16 1998-04-02 Wella Ag Mittel und Verfahren zur Entfärbung von Fasern, sowie Mehrkomponenten-Kit zur Färbung und Entfärbung von Fasern
CA2272306A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Cosmetic compositions
US5782933A (en) * 1997-04-30 1998-07-21 Bristol-Myers Squibb Company Ascorbic and isoascorbic acids to remove or adjust oxidative color in hair
US5981578A (en) * 1997-09-15 1999-11-09 Alexandrides; Ariadne Increased solubilization and stable cosmetic preparations of ascorbic acid
DE19807774A1 (de) * 1998-02-24 1999-08-26 Beiersdorf Ag Verwendung von Flavonen bzw. Flavanonen bzw. Flavonoiden zum Schutze von Ascorbinsäure und/oder Ascorbylverbindungen gegen Oxidation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0057839A1 *

Also Published As

Publication number Publication date
BR0005546A (pt) 2001-01-30
US6482808B1 (en) 2002-11-19
DE19913427A1 (de) 2000-09-28
WO2000057839A1 (de) 2000-10-05
JP2002540128A (ja) 2002-11-26

Similar Documents

Publication Publication Date Title
EP1328242B2 (de) Nicht-therapeutische verwendung von kreatin, kreatinin und/oder deren derivaten zur stärkung und verbesserung der haarstruktur
EP1079793A1 (de) Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien
DE3101011C2 (de) Haarbehandlungsmittel
EP0340592B2 (de) Haarbehandlungsmittel mit natürlichen Inhaltsstoffen
EP1727518B1 (de) Verwendung von mitteln zur kosmetischen behandlung von menschlichen haaren
DE3833681A1 (de) Dauerwellmittel
EP0261387A1 (de) Mittel und Verfahren zur dauerhaften Haarverformung
DE19631685A1 (de) Hydrolytisch spaltbare Wirkstoffderivate, diese enthaltene Haarbehandlungsmittel und Verfahren zum Behandeln von Haaren
DE3615396A1 (de) Mittel zur behandlung der haare und der kopfhaut
DE60222684T2 (de) Haarbehandlungszusammensetzungen und -verfahren
EP1226815A1 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren
DE2542338C3 (de) Mittel zur Festigung der Frisur
DE2607441B2 (de) Hexamethylentetramin enthaltendes desodorierendes Mittel
EP0653201A1 (de) Mittel zur dauerhaften Haarverformung sowie neue haarkeratinreduzierende Cysteinglycerinester
DE19749164C2 (de) Verfahren und Zwischenbehandlungsmittel zur dauerhaften Verformung von menschlichen Haaren
DE4113675A1 (de) Haarbehandlungsmittel
DE4216667C2 (de) Verwendung von alpha-Ketodicarbonsäuren gegen Wasserstoffperoxidreste im Haar
EP0726251A1 (de) Mittel zur dauerhaften Haarverformung sowie neue haarkeratinreduzierende Cysteinester
DE19840190C2 (de) Mittel und Verfahren zur dauerhaften Verformung von menschlichen Haaren und Fixiermittel hierfür
DE102004045353A1 (de) Mittel zur Entfernung von Oxidationshaarfarben
DE3601739A1 (de) Kosmetisches mittel zur behandlung der haare oder der kopfhaut
DE102004017376A1 (de) Vorbehandlungsmittel für eine Epilation
DE19709437C2 (de) Verfahren zur dauerhaften Verformung von menschlichen Haaren
DE19730216C2 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren und Fixiermittel hierfür
DE19610458C1 (de) Kosmetisches Mittel zur Behandlung der Haut oder der Haare

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20061219

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 5/12 20060101AFI20080109BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: WELLA GMBH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 50016237

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61K0007000000

Ipc: A61Q0005120000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/67 20060101ALI20120117BHEP

Ipc: A61Q 5/00 20060101ALI20120117BHEP

Ipc: A61Q 5/12 20060101AFI20120117BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

PUAC Information related to the publication of a b1 document modified or deleted

Free format text: ORIGINAL CODE: 0009299EPPU

REG Reference to a national code

Ref country code: DE

Ref legal event code: R231

Ref document number: 50016237

Country of ref document: DE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG.

Ref country code: CH

Ref legal event code: EP

DB1 Publication of patent cancelled
18W Application withdrawn

Effective date: 20120524

REG Reference to a national code

Ref country code: NL

Ref legal event code: GRER

Effective date: 20120704

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 562670

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120715

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG. DIE ANMELDUNG WURDE VOR DER ERTEILUNG ZURUECKGENOMMEN